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ABSTRACT
Focal adhesions are sites of tight adhesion to the underlying extracellular matrix
developed by cells in culture. They provide a structural link between the actin
cytoskeleton and the extracellular matrix and are regions of signal transduction
that relate to growth control. The assembly of focal adhesions is regulated by the
GTP-binding protein Rho. Rho stimulates contractility which, in cells that are
tightly adherent to the substrate, generates isometric tension. In turn, this leads
to the bundling of actin filaments and the aggregation of integrins (extracellular
matrix receptors) in the plane of the membrane. The aggregation of integrins
activates the focal adhesion kinase and leads to the assembly of a multicomponent
signaling complex.
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INTRODUCTION
The adhesive interactions between a cell and its surrounding extracellular matrix
(ECM) regulate its morphology, migratory properties, growth, and differenti-
ation. One model system for studying adhesion to ECM is the focal adhesion
(FA). FAs are specialized sites of adhesion developed by many cells in culture.
They consist of aggregated ECM receptors (integrins) that span the plasma
membrane, interacting on the outside with ECM components and on the in-
side with bundles of actin filaments (stress fibers). Many proteins have been
identified in FAs, particularly at their cytoplasmic face. Some of these proteins
have predominantly a structural role, whereas others are involved in signal
transduction.
The field of FA research has grown considerably since one of us participated
in writing a review on FAs for this series (Burridge et al 1988). In large part,
this growth reflects the increasing interest in integrin-mediated signaling and
the widely recognized effect integrin-mediated adhesion has on many aspects of
cell behavior. Several excellent recent reviews cover various areas of integrin-
mediated signal transduction and FA research (Adams & Watt 1993, Juliano &
Haskill 1993, Hemler et al 1994, Pavalko & Otey 1994, Clark & Brugge 1995,
Yamada & Miyamoto 1995, Ridley 1995, Richardson & Parsons 1995), includ-
ing two in Volume 11 of this series (Jockusch et al 1995, Schwartz et al 1995).
Our intention here is to avoid repetition of these reviews. Thus we focus on
one topic generally neglected: the relationship between contractility/isometric
tension and the formation of FAs. We believe that this is an area critical to
understanding not only the assembly of these structures but also the signaling
that occurs within them. In this context, we discuss the low molecular weight
GTP-binding protein Rho, which stimulates the formation of FAs and stress
fibers and whose mode of action has generated considerable interest.
STRUCTURAL ORGANIZATION OF FOCAL
ADHESIONS
Many of the structural details of FAs have been reviewed recently (Jockusch
et al 1995). Structural proteins in FAs are listed in Table 1. Several appear to be
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Table 1 Structural components of focal adhesions
Transmembrane Cytoplasmic
1. integrins 4. actin 10. zyxin 16. aciculin*
2. syndecan IV 5. -actinin 11. CRP 17. dystrophin*
3. dystroglycan* 6. filamin 12. radixin 18. syntrophin*
7. vinculin 13. fimbrin 19. utrophin*
8. talin 14. profilin
9. tensin 15. VASP
Components marked with an asterisk are found only in the FAs of specialized
cells types. 1. reviewed by Hynes 1992; 2. Woods & Couchman 1994; 3.
Belkin & Smalheiser 1996; 4. Geiger 1979; 5. Lazarides & Burridge 1975,
Wehland et al 1976; 6. Mittal et al 1987, Pavalko et al 1989; 7. Geiger 1979,
Burridge & Feramisco 1980; 8. Burridge & Connell 1983; 9. Wilkins et al
1986, Wilkins et al 1987, Bockholt et al 1992; 10. Beckerle 1986; 11. Sadler
et al 1992; 12. Sato et al 1992; 13. Bretscher 1981; 14. listed here because
of the binding to VASP; Reinhard et al 1995a; 15. Reinhard et al 1992; 16.
Belkin et al 1994; 17, 18. Kramarcy & Sealock 1990; 19. Belkin & Burridge
1995.
universal FA constituents, whereas others are cell-type specific (e.g. dystrophin,
aciculin, etc). It has not been determined whether some of these components
have structural or signaling functions.
Integrins and Other Transmembrane Components
The major transmembrane components in FAs are integrins, a large family
of transmembrane heterodimers (Hynes 1992). Integrins are classified into
several families according to their  subunits. Most  chains can pair with
multiple  subunits, and a few  subunits pair with more than one  sub-
unit (Hynes 1992). The  and  subunits each span the membrane once and
have large extracellular and short intracellular domains (with the exception of
the 4 cytoplasmic domain, which is 1000 amino acids long and interacts with
the intermediate filament cytoskeleton rather than with microfilaments). Most
of the integrins involved in formation of focal adhesions are members of the
1 or 3 families. Pairing different  subunits with these  chains generates
receptors for many different ECM proteins. A major requirement for FA de-
velopment is that the ECM provides a ligand for integrins expressed on the cell
surface. The type of integrin found within focal adhesions is generally dictated
by the ECM to which cells adhere (Singer et al 1988, Dejana et al 1988, Fath
et al 1989). However, a situation has been described in which a laminin-binding
integrin, 61, not known to interact with fibronectin, was detected in the FAs
of cells adhering to fibronectin (Cattelino et al 1995). For cells grown in serum,
vitronectin is typically the ECM protein adsorbed to the glass or plastic sub-
stratum, and cells expressing the vitronectin receptor v3 will develop FAs
containing this integrin. Probably the most frequently studied FAs are those
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made by cells plated on surfaces coated with fibronectin. These FAs involve
the major fibronectin receptor 51.
Both the vitronectin receptor v3 and the fibronectin receptor 51 recog-
nize the sequence RGD within their respective ligands (Hynes 1992; Ruoslahti,
this volume). Massia & Hubbell studied the adhesion of cells plated directly
onto RGD peptides covalently attached to substrates. At very low densities,
cells attach but do not spread. At higher densities, when the spacing between
peptides reaches 440 nm, cells spread but do not form FAs. However, at still
higher densities of RGD peptides, with a spacing of  140 nm or less, spread-
ing is accompanied by development of FAs (Massia & Hubbell 1991). This
requirement for a high density of integrin ligands suggests that the interacting
integrins need to be clustered in order for FAs to form.
The development of FAs has been studied in cells adhering to cell-binding
fragments of fibronectin that contain the RGD sequence. Whereas some in-
vestigators observed FAs on these domains of fibronectin (Singer et al 1987),
others noted their failure to form (Beyth & Culp 1984, Izzard et al 1986, Woods
et al 1986) or that the FAs were small and abnormal (Streeter & Rees 1987).
Woods and coworkers found that assembly of FAs on the cell-binding fragment
of fibronectin was stimulated by addition of a proteoglycan-binding domain of
fibronectin (Woods et al 1986). Alternatively, the cells could be stimulated with
phorbol esters to activate protein kinase C (PKC) (Woods & Couchman 1992).
The reason why FA formation on the cell-binding fragment of fibronectin re-
quires this additional stimulation has been a puzzle, given that simple clustering
of integrins with antibodies seems to mimic their formation. A possible ex-
planation has been suggested by Hotchin & Hall (1995) who have found that
active Rho is required for FAs to form on intact fibronectin. In some situa-
tions, PKC stimulation has been reported to activate Rho (Hall 1994), which
raises a question about the state of Rho in the experiments examining FA for-
mation on fibronectin fragments. Was Rho relatively inactive in the cells that
failed to form FAs on fibronectin fragments, and did it become activated by the
proteoglycan-binding domains of fibronectin or by PKC stimulation? The role
of Rho in clustering integrins into FAs is discussed below.
A transmembrane proteoglycan, syndecan 4, has been identified in the FAs of
many different cell types adhering to various ECM proteins (Woods & Couch-
man 1994). In serum-starved cells, syndecan 4 is absent from FAs but can be
recruited by stimulating with serum or by activating PKC (Baciu & Goetinck
1995). When cells are plated on fibronectin in the presence of serum, the local-
ization of syndecan 4 to FAs increases with time and is more associated with
mature FAs rather than with newly forming ones at the leading edge (Baciu
& Goetinck 1995). The late recruitment of syndecan 4 to FAs suggests that it
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is not involved in the early signaling events associated with FA formation. It
will be important to investigate the interactions of the syndecan cytoplasmic
domain with structural and signaling components.
Dystroglycan (cranin, laminin-binding protein 120) (Smalheiser & Schwartz
1987, Douville et al 1988, Ibraghimov-Beskrovnaya et al 1992, 1993, Gee et al
1993, Smalheiser & Kim 1995) is a transmembrane receptor for laminin, un-
related to integrins that has been identified in the FAs of several cell types
(Belkin & Smalheiser 1996). It has been studied mainly in the context of
skeletal muscle, where it binds dystrophin and is in a complex with sev-
eral dystrophin-associated glycoproteins (Ibraghimov-Beskrovnaya et al 1992,
Ervasti & Campbell 1993a,b). However, dystroglycan is quite widely dis-
tributed (Smalheiser & Schwartz 1987, Ibraghimov-Beskrovnaya et al 1993).
It remains to be determined whether its presence in FAs is due to a direct asso-
ciation with some of the major structural proteins of FAs, such as talin, vinculin
and -actinin, or whether it is associated indirectly via dystrophin or utrophin
which, in turn, may be interacting with other components at these sites.
Integrin Cytoplasmic Domains
The cytoplasmic domains of integrins are critical for FA formation. Many
of their structural features and interactions have been reviewed by Sastry &
Horwitz (1993). The role of the cytoplasmic domains in targeting 1 and 3
integrins to FAs has been studied using mutations, deletions, and chimeric
constructs. Deletion of the 1 cytoplasmic domain blocks FA localization of
integrin heterodimers (Solowska et al 1989, Marcantonio et al 1990, Hayashi
et al 1990), whereas chimeric constructs containing the 1 cytoplasmic domain
fused to unrelated receptors target to FAs (Geiger et al 1992b, LaFlamme et al
1992). Consistent with this, deletion of  cytoplasmic domains drives integrin
heterodimers to FAs (Briesewitz et al 1993, Ylanne et al 1993). These results
indicate that the  subunit cytoplasmic domain is responsible for targeting an
integrin to FAs, whereas the  subunit cytoplasmic sequence inhibits FA local-
ization. Ligand binding relieves this inhibition (LaFlamme et al 1992). The
relationship of the  and  subunit cytoplasmic domains has not been fully re-
solved, but in the nonligand-bound state, the two cytoplasmic domains appear
to be in a close proximity (Briesewitz et al 1995). Following ligand binding
to the extracellular domain, a conformational change is transmitted to the cy-
toplasmic domains, allowing the  cytoplasmic region to interact with focal
adhesion components. Deletion of the  cytoplasmic domain or expression of
the  cytoplasmic domain on its own as a chimeric protein appears to mimic
the ligand-bound state.
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A key question is whether ligand occupancy increases the affinity of inter-
action between integrins and cytoskeletal proteins. Miyamoto and colleagues
compared the effects of integrin clustering with ligand occupancy (Miyamoto
et al 1995a). Integrins were aggregated on the surface of cells using beads coated
with non-inhibitory antibodies or with antibodies that block integrin function.
Integrin clustering by non-inhibitory antibodies stimulates the colocalization
of tensin and focal adhesion kinase (FAK), but not talin, vinculin, -actinin,
or actin. Clustering integrins with inhibitory antibodies (which mimic ligand
binding), or with non-inhibitory antibodies in the presence of soluble ligands,
stimulates co-clustering of talin, vinculin, -actinin, and actin. These results
argue that, while clustering alone will recruit some proteins, additional proteins
are recruited in response to the combination of clustering and ligand occupancy.
It may be that ligand occupancy is itself sufficient to induce this association
between integrins and these cytoskeletal proteins, but this is difficult to resolve
experimentally. Earlier work by this group, in which soluble ligands were seen
to drive integrins into FAs formed by other integrins, strongly supports the idea
that integrin occupancy is itself sufficient to induce cytoskeletal association
with integrins (LaFlamme et al 1992).
Alternatively spliced cytoplasmic domains have been identified for both 1
and 3 integrin subunits. These differ in their ability to support FAs or target
to these structures. In humans, four alternatively spliced isoforms of 1 have
been identified and are referred to as 1A and 1B (Balzac et al 1993, 1994), 1C
(Languino & Ruoslahti 1992), and 1D (van der Flier et al 1995, Zhidkova et al
1995, Belkin et al 1996). Recent genomic analysis of the mouse 1 integrin
gene located only the exons for 1A and 1D (Baudoin et al 1996), which raises
the possibility that the 1B and 1C variants emerged late in the evolution of the
1 integrin family. 1A is the predominant and original isoform identified. In
humans, 1B and 1C appear to be relatively minor forms and are not found in
FAs.
1B may be involved in regulation of adhesion and migration (Balzac et al
1993, 1994), whereas 1C exerts a negative effect on growth (Meredith et al
1995, Fornaro et al 1995) (discussed below). In contrast to the low levels of
expression of 1B and 1C, the major 1 integrin isoform in striated muscles
is 1D (van der Flier et al 1995, Zhidkova et al 1995, Belkin et al 1996),
which is found at all sites of actin filament-membrane attachment (Belkin et al
1996). Unlike the other isoforms, 1D and 1A share significant sequence
homology in their alternatively spliced regions. 1D is found in FAs, both in
cultured myotubes and when transfected into nonmuscle cells (Belkin et al
1996). It has been speculated that 1D interacts not only with the structural
proteins of FAs but also with the specialized cytoskeletal proteins that line the
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muscle sarcolemma (Belkin et al 1996).1 integrins appear to associate with the
dystrophin-containing lattice in muscle development (Lakonishok et al 1992).
The forces transmitted across the sarcolemma of striated muscles are much
greater than those experienced by the plasma membranes of most other cells.
These high forces may have generated the need for a unique integrin isoform
to provide stronger attachments to the membrane.
Cytoplasmic Proteins
Recently, the number of proteins identified at the FA cytoplasmic face has ex-
panded greatly (Table 1). So too have the number of interactions (Table 2). It
has become difficult, if not impossible, to represent this complexity adequately
(Figure 1). Several components, as well as interactions, have not been included.
The diagram conveys neither the dynamic nature of many of the interactions
nor the stoichiometry of the components. The relative abundance of FA con-
stituents varies considerably; FAK, paxillin, tensin, zyxin, and many signaling
components are minor compared with vinculin and talin. We are confident that
more FA proteins will be discovered and that the complexity of interactions will
increase further. Space limitations restrict our discussion to a few topics rele-
vant to the assembly of these structures. More information about FA structural
proteins is given elsewhere (Jockusch et al 1995).
One striking observation is that a large number of FA proteins bind actin.
This large number hints at redundancy in the linkage of actin filaments to inte-
grins (and possibly to other transmembrane components in FAs). Some of the
actin-binding proteins may function at different stages in the life of a FA. It has
been suggested, for example, that talin and vinculin may be involved in FA for-
mation, whereas -actinin may be more important in maintaining or stabilizing
microfilament attachment in mature FAs (DePasquale & Izzard 1987, 1991,
Pavalko & Burridge 1991, Nuckolls et al 1992). Multiple linkages may also
facilitate actin polymerization, permitting addition of actin monomers while
Table 2 Interactions between structural proteins in focal adhesions
Integrin Actin -actinin Fimbrin Profilin Radixin Talin Tensin VASP Vinculin Zyxin
Integrin — — 1 — — — 2 — — — —
Actin — — 3 4 5 6 7 8 9 10 —
-actinin 1 4 — — — — — — — 11 12
VASP — 9 — — 13 — — — — — 14
Vinculin — 10 — — — — 15 16 — — —
1. Otey et al 1990; 2. Horwitz et al 1986; 3. Burridge & Feramisco 1980; 4. Bretscher 1981; 5. Lassing & Lindberg 1985; 6.
Tsukita & Hieda 1989; 7. Muguruma et al 1990, Kaufmann et al 1991; 8. Wilkins et al 1987, Lo et al 1994; 9. Reinhard et al
1992; 10. Menkel et al 1994, Johnson & Craig 1995a; 11. Belkin & Koteliansky 1987, Wachsstock et al 1987; 12. Crawford
et al 1992; 13. Reinhard et al 1995a; 14. Reinhard et al 1995b; 15. Burridge & Mangeat 1984; 16. Wilkins et al 1987.
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Figure 1 A focal adhesion. The model shows some of the interactions determined in vitro for
proteins within focal adhesions formed on a surface coated with fibronectin (FN) or vitronectin
(VN). For the sake of clarity, so that linking proteins can be visualized, integrins are shown dispersed
rather than clustered. They are linked to actin microfilaments via talin, vinculin and/or -actinin.
Actin polymerization at these sites may involve either tensin or profilin, which interacts with VASP,
a zyxin-binding protein. A few of the signaling components (FAK, paxillin, p130cas, src family
kinases) have also been included; however, several FA proteins and many of the interactions have
been omitted. It should be noted that the diagram misrepresents the stoichiometry of components
in focal adhesions, i.e. some such as vinculin and talin appear to be many times more abundant
than others, such as FAK, paxillin, tensin, and zyxin.
simultaneously maintaining attachment to the membrane. It is noteworthy that
some FA proteins, including tensin and talin, have multiple actin-binding sites
(Lo et al 1994; L Hemmings et al, manuscript submitted). These may also
permit subunit addition while maintaining attachment, as has been suggested
for insertin, a fragment of tensin (Weigt et al 1992, Ruhnau et al 1989). Addi-
tionally, multiple binding sites may cross-link actin filaments and thus stabilize
attachments to the membrane.
The attachment of actin filaments to integrins in FAs remains poorly under-
stood. Both talin and -actinin were shown to bind to integrins in vitro with
relatively low affinity (Horwitz et al 1986, Otey et al 1990). A talin-binding
site within the 1A cytoplasmic domain corresponding to residues 780–789 was
mapped using synthetic peptides (Tapley et al 1989). Work from this laboratory,
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however, indicates that sequences along most of the length of the cytoplasmic
domain contribute to talin binding (K Simon, unpublished observations). In
the case of -actinin, peptide-binding studies indicate that two regions in the
cytoplasmic domain are involved, residues 768–778 and 785–794 (Otey et al
1993). It has been difficult to demonstrate that these interactions also occur in
vivo. Working with neutrophils, Pavalko and coworkers demonstrated coim-
munoprecipitation of -actinin and 2 integrin (Pavalko & LaRoche 1993). In
an attempt to get at the in vivo associations of proteins with integrin cytoplasmic
domains, Lewis & Schwartz (1995) transfected full-length or truncated chicken
1 integrins into mouse fibroblasts and examined the colocalization of proteins
with these integrins after they had been clustered with antibody-coated beads.
This provided a way to map regions of the 1 cytoplasmic domain responsible
for recruiting specific proteins. Deletion of the last 13 residues at the C-terminus
inhibits colocalization of talin, actin, and FAK with clustered integrins. Inter-
estingly, -actinin continues to codistribute with integrins; this is blocked by
deletion of an additional 15 residues. These experiments support the idea that
talin binding to integrins is required for attachment of actin and that, on its own,
-actinin is insufficient to recruit actin filaments to clustered integrins.
The localization of -actinin to FAs has been controversial. Although it is
usually listed as a FA component, it is often not detected in FAs by immunoflu-
orescence or electron microscopy even though it is prominent along the associ-
ated stress fibers (Zigmond et al 1979, Chen & Singer 1982, Samuelsson et al
1993). However, when labeled -actinin is microinjected, it readily targets to
FAs (Feramisco 1979, McKenna et al 1985, Sanger et al 1987). Pavalko and
coworkers provided evidence that the inability to detect -actinin in FAs by
immunofluorescence results from inaccessibility of the -actinin to antibodies
(Pavalko et al 1995). FAs are dense structures and this may limit antibody
accessibility.
Vinculin is one of the most abundant FA proteins, interacting with talin,
-actinin, tensin, and paxillin. For many years, the reported interaction of vin-
culin with actin was controversial. The demonstration by Jockusch’s group that
a vinculin tail domain construct binds actin (Menkel et al 1994) was difficult
to reconcile with the inability of several groups to find significant actin binding
with intact vinculin (e.g. Evans et al 1984, Otto 1986). A breakthrough came
with the discovery by Johnson & Craig of an intramolecular, head-tail interac-
tion within vinculin (Johnson & Craig 1994). This interaction masks binding
sites for both talin and actin in vinculin’s head and tail domains, respectively
(Johnson & Craig 1994, 1995a). It seems likely that exposure of these sites
is an important event in the assembly of FAs. It is notable that vinculin binds
acidic phospholipids (Niggli et al 1986, Isenberg 1991), in particular PIP2
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(Fukami et al 1994), and that the binding site for PIP2 is located in the hinge
region between the head and tail domains (Johnson & Craig 1995b). These
observations prompted examination of the effects of lipids, specifically PIP2,
on the conformation of vinculin. It was shown that the head-tail interaction of
vinculin could be dissociated by acidic phospholipids and most effectively by
PIP2 (Weekes et al 1996, Gilmore & Burridge 1996). This exposed the binding
sites for actin and talin, and a potential PKC phosphorylation site in the tail of
vinculin. Vinculin immunoprecipitated from adherent cells contained PIP2, but
not other phospholipids, consistent with PIP2 being the physiological effector
of the conformational change (Gilmore & Burridge 1996).
Significantly, PIP2 levels are elevated in response to adhesion in a Rho-
dependent manner (Chong et al 1994). These observations are discussed in
more detail below in the context of FA assembly.
Zyxin is one of the less abundant proteins present in FAs and adherens junc-
tions (Beckerle 1986). This 82-kDa protein, expressed most prominently in
fibroblasts and muscle cells, contains a proline-rich stretch at the C-terminus,
involved in binding -actinin (Crawford et al 1992), and three N-terminal LIM
domains (Sadler et al 1992). LIM domains, each composed of two histidine-
and cysteine-rich zinc fingers, mediate specific protein-protein interactions
(Schmeichel & Beckerle 1994). They have been identified in a number of
proteins, some of which are transcription factors, whereas others, such as the
cysteine-rich proteins (CRP), are made up almost entirely of LIM domains.
Zyxin does not contain an obvious nuclear targeting sequence, but truncation
of the proline-rich N-terminus induces nuclear localization of zyxin (Nix &
Beckerle 1995). In addition, a 44-amino acid sequence within the proline-rich
region localizes zyxin to FAs. This raises the exciting possibility that zyxin
shuttles between FAs and the nucleus in response to other factors interacting
with this domain. The first LIM domain of zyxin binds to CRP, which is also
localized in FAs (Sadler et al 1992, Crawford et al 1994). Expression of CRP
proteins is tightly regulated during myogenesis and these proteins have been
shown to potentiate muscle differentiation.
Another interesting interaction occurs between zyxin and VASP (M Rein-
hard et al 1995). VASP (vasodilator-stimulated phosphoprotein) was originally
identified in platelets (Halbrugge & Walter 1989) as a major substrate of the
cAMP-dependent protein kinase (PKA) and the cGMP-dependent protein ki-
nase (PKG), both of which are stimulated by agents that inhibit platelet acti-
vation. Subsequently, VASP was identified in fibroblast FAs and along stress
fibers, as well as in membrane ruffles (Reinhard et al 1992, Haffner et al 1995).
VASP contains a polyproline-rich sequence that binds profilin (M Reinhard et al
1995), thus indicating a possible function in the control of actin polymerization.
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This idea has received strong support from studies on the movement of Liste-
ria monocytogenes. Listeria moves inside host cells by rapid polymerization
of actin filaments at one pole of the bacterium (Pollard 1995). Both profilin
and VASP have been identified at this site (Theriot et al 1994, Chakraborty
et al 1995). VASP binds to the Listeria protein ActA (Pistor et al 1995),
which is responsible for bacterial motility, and suggests that VASP provides a
bridge between the bacterium and the microfilament system. Some sequence
homology exists between ActA and zyxin, and these proteins even cross re-
act immunologically (R Goldsteyn & E Friederich personal communication).
These observations suggest that zyxin, VASP, and profilin function as a com-
plex, regulating the nucleation of actin polymerization at FAs and equivalent
sites in cells. How important actin polymerization is in a stable FA is not clear.
It is probably more important in the initial stages of FA development, during
the assembly of stress fibers and FAs. This may explain why profilin is gen-
erally not detected in mature FAs (Buss et al 1992). An unanswered question
concerns the role of VASP phosphorylation by the cyclic nucleotide-dependent
protein kinases.
CONTRACTILITY: INFLUENCE ON THE FORMATION
OF STRESS FIBERS AND FOCAL ADHESIONS
It had been suggested that stress fibers contract isometrically and that this
isometric tension contributes to their assembly (Heath & Dunn 1978, Burridge
1981). Numerous observations contributed to this hypothesis. For example,
stress fibers contain many of the contractile proteins found in muscle, including
actin and myosin II, and these are arranged in a sarcomeric type of organization
(Weber & Groesche-Stewart 1974, Lazarides & Burridge 1975, Gordon 1978,
Kreis & Birchmeier 1980). Although this pattern is suggestive of a contractile
function, stress fibers are rarely seen to shorten in living cells. However, they
are potentially contractile, as revealed in permeabilized cells exposed to ATP
(Isenberg et al 1976, Kreis & Birchmeier 1980, Crowley & Horwitz 1995). It
was argued that shortening usually cannot occur because of the strong adhesion
at FAs to a rigid substratum, which generates isometric tension. A visible
manifestation of tension exerted on the underlying substrate is seen when cells
are grown on flexible silicone rubber surfaces. Fibroblasts and other cells
that have prominent stress fibers visibly wrinkle these substrates (Harris et al
1980). Detachment of cells from the rubber results in the rapid loss of wrinkles.
Evidence that isometric tension can generate bundles of microfilaments comes
from studies using cytoplasmic extracts of Physarum induced to contract under
isotonic or isometric conditions (Fleischer & Wohlfarth-Bottermann 1975).
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Isometric contraction generates dense arrays of microfilaments, reminiscent of
stress fibers. These structures rapidly disassemble upon the release of tension,
just as stress fibers disassemble when cells are detached from a substrate. In
contrast, when the cytoplasmic extracts are stimulated to contract under isotonic
conditions, shortening is not accompanied by the development of large bundles
of microfilaments (Fleischer & Wohlfarth-Bottermann 1975).
Much additional evidence supports the idea that isometric tension contributes
to the formation of stress fibers. For example, fibroblasts contract collagen gels
in which they are suspended. Free-floating gels may be contracted over several
days to as little as 10% of their original size, and the fibroblasts in these gels
lack stress fibers. If the gels are anchored, isometric tension is generated and
the fibroblasts develop prominent stress fibers (Mochitate et al 1991, Tomasek
et al 1992, Tomasek & Haaksma 1991, Grinnell 1994, Halliday & Tomasek
1995). Upon release of tension in anchored gels, there is a rapid contraction
of the gel followed by disassembly of the stress fibers (Mochitate et al 1991,
Tomasek et al 1992, Grinnell 1994). Application of tension to cells in culture
also stimulates the formation of stress fibers (Franke et al 1984). When tension
is applied to a localized region of the cell surface, a bundle of actin filaments
is induced immediately subjacent to the site of applied tension (Kolega 1986).
Danowski demonstrated that when contractility is stimulated in fibroblasts by
microtubule depolymerization, formation of stress fibers is induced (Danowski
1989). Under these conditions, FAs are also stimulated to form (B Geiger &
A Bershadsky, personal communication; M Chrzanowska-Wodnicka, unpub-
lished observations). How microtubule depolymerization stimulates contrac-
tility has not been established. One set of models has invoked “tensegrity”
theories, in which microfilaments are viewed as tension-generating elements
and microtubules as compression-resisting struts (Ingber 1993, Buxbaum &
Heidemann 1988). The collapse of the compression-resisting elements, the
microtubules, should lead to increased contractility. However, an alternative
interpretation has been suggested by Kolodney & Elson, who have demon-
strated enhanced myosin light chain (MLC) phosphorylation in response to
microtubule depolymerization. This suggests that microtubule depolymeriza-
tion directly activates actomyosin contractility, rather than simply removing an
opposing structural element (Kolodney & Elson 1995).
Agents that inhibit contractility promote stress fiber and FA disassembly.
For example, stress fibers are disrupted by microinjection of antibodies that
bind to the myosin rod domain and inhibit myosin filament assembly (Honer
et al 1988). Butanedione monoxime (BDM) inhibits myosin ATPase activity
(Higuchi & Takemori 1989, McKillop et al 1994, Cramer & Mitchison 1995),
decreases fibroblast contractility, and leads to the reversible disassembly of
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both stress fibers and FAs (Chrzanowska-Wodnicka & Burridge 1996). It has
been long known that high cAMP levels disrupt stress fibers in many cell types.
Pursuing the basis for this, Lamb and coworkers related the effects of high
cAMP to decreased MLC phosphorylation (Lamb et al 1988). Elevated PKA
activity disrupts stress fibers and leads to phosphorylation of the MLC kinase
(MLCK), which has been correlated with decreased activity in vitro. MLCK is
a key protein regulating nonmuscle actin-myosin interaction and contractility
(see below). Further evidence for a role for MLCK in stress fiber stability was
obtained by microinjection of antibodies against the MLCK into cells. The
antibodies immunoprecipitated MLCK and led to the disassembly of stress
fibers (Lamb et al 1988). The FAs were not examined in these experiments,
but in a separate study, elevation of cAMP in the same cell type disrupted FAs
(Turner et al 1989). Pharmacological agents that inhibit MLCK also inhibit
contractility and lead to stress fiber and FA disassembly (Volberg et al 1994,
Chrzanowska-Wodnicka & Burridge 1996). MLC phosphorylation can also be
modulated by protein phosphatases. Elevating the level of protein phosphatase
1 (PP1) in fibroblasts by microinjection decreases MLC phosphorylation, which
leads to a rapid loss of stress fibers (Fernandez et al 1990).
Taken together, this large body of evidence supports the idea that isometric
tension induced by contractility drives the formation of stress fibers and FAs.
Conversely, these structures disassemble when contractility is inhibited or ten-
sion is released. Some agents that stimulate formation or disassembly of FAs
may exert their primary effects on contractility. For this reason, and because
nonmuscle contractility can be modulated in many different ways, we discuss
the regulation of contractility in the next section.
Regulation of Contractility
Much of what is known about the regulation of vertebrate nonmuscle contrac-
tility is derived from work on vertebrate smooth muscle. Many, but not all, of
the regulatory components are present in both systems. In smooth muscle and
nonmuscle cells, the dominant regulatory system involves phosphorylation of
the myosin regulatory light chains (20 kDa) by a MLCK (Figure 2). MLCK
phosphorylates both Ser-19 and Thr-18 (Sellers 1991, Tan et al 1992). Ser-19 is
the major site of phosphorylation induced by agonists that stimulate light chain
phosphorylation. Thr-18 is phosphorylated at a slower rate but becomes phos-
phorylated under conditions of maximal stimulation. The phosphorylation of
the regulatory light chain increases the actin-activated ATPase activity of both
smooth and nonmuscle myosin II (Adelstein & Conti 1975) and is required
for myosin-driven actin filament movement in in vitro motility assays (Sellers
1991, Tan et al 1992). This regulation of myosin motor function may be the
primary role of this light chain phosphorylation.
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Figure 2 Regulation of contractility in smooth muscle and nonmuscle cells. The interaction of
myosin with actin is regulated by phosphorylation of the regulatory myosin light chains (MLC)
as well as by the actin-binding proteins, caldesmon and calponin. Active proteins are shaded,
inactive are blank. MLC phosphorylation on Ser-19 and Thr-18 is catalyzed by the MLCK, which
is activated by binding Ca2C/calmodulin. The same sites on MLCs can also be phosphorylated by
CaM kinase II (CaMKII). MLCK is inhibited by phosphorylation by PKA, PKG, or CaM kinase
II. MLC dephosphorylation occurs by a myosin phosphatase (mPP), which is inhibited in smooth
muscle by activated Rho-stimulates Rho-kinase, which phosphorylates mPP, thereby inhibiting it
activity (Kimura et al 1996). The myosin phosphatase is also inhibited by arachidonic acid, which
may be generated by activation of PKC. Inhibitory phosphorylation of MLCs occurs primarily
on Ser-1 and Ser-2, but also on Thr-9 in vitro, and is catalyzed by PKC and the mitotic kinase
p34cdc2 (cdc2). The actin-binding proteins, caldesmon and calponin, inhibit the interaction of
myosin with actin in the absence of Ca2C. In the presence of Ca2C, the inhibition is relieved
either by phosphorylation of caldesmon or calponin, or by binding Ca2C/calmodulin. Phosphory-
lation of caldesmon by p34cdc2 also releases caldesmon from actin.
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Regulatory light chain phosphorylation also induces a conformational change
in the myosin monomer (Craig et al 1983, Citi & Kendrick-Jones 1986, Ikebe
& Reardon 1990) that might be involved in control of thick filament assembly.
Nonmuscle myosin II can exist in two conformational states. In the first, the
myosin rod is folded back on itself and interacts with the myosin heads. The
second conformation is elongated, resembling the classical conformation of
isolated skeletal muscle myosin (Citi & Kendrick-Jones 1986). In the folded
conformation, myosin cannot assemble into filaments. The equilibrium between
the two conformational states is shifted by phosphorylation of Ser-19. This fa-
vors the extended conformation and promotes assembly of myosin filaments.
Phosphorylation of Thr-18 stabilizes the extended conformation and may also
enhance filament formation (Ikebe 1989, Ikebe et al 1988). In lower organisms,
such as Dictyostelium, phosphorylation of the heavy chains inhibits myosin fil-
ament assembly (Tan et al 1992). In vertebrate smooth and nonmuscle cells,
heavy chain phosphorylation also occurs. Whether this phosphorylation regu-
lates myosin filament assembly has not been determined, although it seems a
likely possibility.
The MLCK from smooth muscle and nonmuscle cells is regulated by Ca2C/
calmodulin binding. In the resting state, in the absence of intracellular cal-
cium, an auto-inhibitory domain blocks the kinase domain within MLCK (Tan
et al 1992). Elevation of intracellular calcium results in calmodulin binding
to MLCK. This causes a conformational shift of the auto-inhibitory domain,
which activates the kinase. The interaction of MLCK with calmodulin is addi-
tionally regulated by phosphorylation. PKA, PKG, and CaM kinase II can all
phosphorylate MLCK at a site that decreases its affinity for Ca2C/calmodulin,
thus inhibiting MLCK activity (Nishikawa et al 1984, Tansey et al 1994). A
novel isoform of MLCK (embryonic MLCK) has recently been identified in
nonmuscle cells (Gallagher et al 1995). This is the predominant or only MLCK
expressed by some cells, whereas elsewhere this MLCK is coexpressed with
the smooth muscle isoform. This embryonic MLCK is regulated by calcium,
but little else is known about its regulation. The MLCK from Dictyostelium
does not have a Ca2C/calmodulin binding site, and its regulation remains to be
elucidated (Tan et al 1992).
Dephosphorylation of MLCs counteracts the effect of their phosphorylation
and provides a target for regulating myosin/actin interaction. The predominant
myosin phosphatase (mPP), an isoform of PP1, consists of three subunits: a 37-
kDa catalytic subunit, a 130-kDa subunit that targets the phosphatase to myosin,
and a 20-kDa subunit (Alessi et al 1992, Shimizu et al 1994, Shirazi et al 1994).
Dissociation of the catalytic subunit from the other components decreases its
activity and is one mechanism by which agonists such as arachidonic acid may
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stimulate contractility (Gong et al 1992, Somlyo & Somlyo 1994). Another
mechanism for regulating mPP activity is by phosphorylation of the 130-kDa
myosin-binding subunit (Trinkle-Mulcahy et al 1995, Ichikawa et al 1996).
In permeabilized smooth muscle cells, ATP-γ -S promoted contractility and
elevated MLC phosphorylation at low calcium concentrations. This was due to
decreased mPP activity and correlated with thiophosphorylation of the 130-kDa
subunit of mPP (Trinkle-Mulcahy et al 1995). Studying purified mPP, Ichikawa
and coworkers (1996) demonstrated the presence of a kinase associated with
the phosphatase. This kinase phosphorylated the 130-kDa subunit, decreasing
phosphatase activity. Kaibuchi and colleagues have shown that activated Rho
stimulates Rho-kinase to phosphorylate the 130-kDa subunit of mPP, thereby
inhibiting mPP activity (Kimura et al 1996) (see below).
The regulatory light chains of smooth and nonmuscle myosins are substrates
for other kinases in addition to MLCK. CaM kinase II can phosphorylate Ser-
19, the same site that is phosphorylated by MLCK (Tan et al 1992). However,
because the affinity of CaM kinase II for Ca2C/calmodulin is 100-fold less than
that of MLCK, it may not be relevant under most conditions. PKC phosphory-
lates the regulatory light chain on three sites in vitro, Ser-1, Ser-2, and Thr-9,
and the two serines have also been observed to be phosphorylated in vivo (Tan
et al 1992). Phosphorylation at these sites decreases the actin-activated ATPase
of myosin previously phosphorylated by MLCK and impairs myosin filament
stability (reviewed in Tan et al 1992). The action of PKC is essentially antag-
onistic to MLCK with regard to myosin activity and contractility. p34cdc2 also
phosphorylates the regulatory light chains on Ser-1 and Ser-2 (Satterwhite et al
1992). The phosphorylation on Ser-1 and Ser-2 is high in mitotically arrested
cells and remains high during mitosis until anaphase, when the contractile ring
begins to develop. At this point there is decreased phosphorylation on Ser-1
and Ser-2 and increased phosphorylation on Ser-19 (Satterwhite et al 1992,
Yamakita et al 1994).
These results have led to the hypothesis that light chain phosphorylation by
p34cdc2 inhibits contractility during mitosis until the onset of cytokinesis, at
which point contractility is important for the contractile ring and the develop-
ment of the cleavage furrow. The loss of stress fibers and FAs in mitotic cells
is striking and correlates well with decreased contractility induced by p34cdc2.
This also supports the idea that the presence of stress fibers and FAs depends
on contractility and that inhibition of contractility leads to disassembly of these
structures.
Although light chain phosphorylation is a major regulatory target for smooth
muscle and nonmuscle contractility, other regulatory proteins have also been
identified (Figure 2). Caldesmon and calponin, two calcium-regulated proteins
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found on smooth muscle thin filaments, inhibit the actin-activated myosin ATP-
ase in vitro in the absence of calcium. Nonmuscle cells contain a lower molec-
ular weight isoform of caldesmon, which lacks a central domain of the smooth
muscle caldesmon. Although the nonmuscle form of caldesmon is signifi-
cantly smaller, its properties appear to be similar to the smooth muscle form.
Caldesmons bind both actin and myosin (Matsumura & Yamashiro 1993). To-
gether with tropomyosin, caldesmon binding to actin filaments increases their
stability and resistance to severing by gelsolin in vitro (Ishikawa et al 1989a,b).
In reconstituted systems, caldesmon has been shown to inhibit tropomyosin-
stimulated, actin-activated myosin ATPase (Yamashiro et al 1995). This effect
of caldesmon results from its binding to actin and is lost in the presence of
Ca2C and calmodulin, which release caldesmon from the actin-myosin com-
plex and permit actin-myosin interaction. Caldesmon is phosphorylated by
several serine/threonine kinases in vitro (Matsumura & Yamashiro 1993), and
the phosphorylation of caldesmon has been reported to affect its interactions
with the actomyosin system. In particular, phosphorylation of caldesmon by
p34cdc2 may be one of the events regulating reorganization of the actin cytoskele-
ton during mitosis (Yamashiro et al 1990, 1991). Phosphorylated caldesmon
dissociates from microfilaments, which may promote microfilament severing
by gelsolin, thereby contributing to the mitotic disassembly of stress fibers.
Calponin is a 35-kDa protein found primarily in smooth muscle, although it
is reported also to be also in some nonmuscle cells (Takeuchi et al 1991). It reg-
ulates myosin ATPase activity in a phosphorylation-dependent fashion. When
not phosphorylated, it binds to actin and inhibits the Mg ATPase activity of
myosin in vitro. Phosphorylation of calponin by PKC or the Ca2C/calmodulin-
dependent protein kinase II relieves this inhibition (Winder & Walsh 1990).
Calponin phosphorylation increases in parallel with MLC phosphorylation as
smooth muscle is induced to contract by activating with carbachol or with
okadaic acid, which inhibits the intrinsic phosphatases, consistent with a role
of calponin phosphorylation in regulating the contractility of smooth muscle
(Winder & Walsh 1990).
RHO
A major regulator of FAs and stress fibers is the small GTP-binding protein
Rho (Hall 1994, Takai et al 1995), which is a member of the ras superfam-
ily of proteins. In mammalian cells, it belongs to a subfamily that consists of
Rho, rac, cdc42, TC10, and rhoG. Each of these proteins has several closely
related isoforms (Hall 1994). In addition to other functions, these Rho-related
proteins regulate the organization of the actin cytoskeleton. Whereas Rho reg-
ulates FAs and stress fibers (Ridley & Hall 1992), Rac promotes membrane
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ruffling (lamellipodia) (Ridley et al 1992), and cdc42 promotes the extension
of microspikes (filopodia) (Nobes & Hall 1995). Here we concentrate on the
effects and mechanism of Rho (Table 3).
The functions of Rho have been studied using two powerful tools: The first is
the Clostridium botulinum C3 exotransferase (C3), which ADP-ribosylates and
inactivates Rho (Narumiya et al 1988, Sekine et al 1989, Aktories & Hall 1989).
The second is a recombinant, constitutively activated Rho, which is generated
by mutating glycine-14 within rho’s effector domain to valine (Val-14rho). This
mutation is equivalent to the Val-12 activating mutation in ras, which decreases
GTPase activity. The disruption of stress fibers by the C3 exotransferase first
indicated a function for Rho in the regulation of actin filaments (Chardin et al
1989). This work was extended by Paterson and colleagues who introduced
constitutively activated Rho into cells, stimulating their development of a con-
tracted morphology (Paterson et al 1990). Microinjection of activated Rho into
quiescent mouse fibroblasts lacking stress fibers and FAs rapidly induces these
structures to form (Ridley & Hall 1992). The quiescent fibroblast system has
Table 3 Effects of Rho
Cell type References
Cytoskeletal effects
Regulation of cell morphology Vero cells Chardin et al 1989
Swiss 3T3 fibroblasts Paterson et al 1990
Induction of stress fibers Swiss 3T3 fibroblasts, Ridley & Hall 1992
mast cells, Price et al 1995
MDCK epithelia Ridley et al 1995
Induction of actin polymerization Mast cells Norman et al 1994
Regulation of cell motility Neutrophils, Takaishi et al 1993
mouse 308R Takaishi et al 1994
Swiss 3T3 cells Stasia et al 1991
Inhibition of SF/HGF-induced motility MDCK epithelia Ridley et al 1995
Cell division, Xenopus embryos, Kishi et al 1993
cleavage furrow formation sand dollar eggs Mabuchi et al 1993
Enhancement of contractility Smooth muscle Hirata et al 1992
CaC2 sensitization Smooth muscle Kokubu et al 1995
Neurite retraction and cell rounding Neurons Jalink et al 1994
MLC phosphorylation Smooth muscle Noda et al 1995
Regulation of integrins
Inhibition of integrin-dependent Monocytes Aepfelbacher 1995
adhesion to fibronectin
Integrin-dependent aggregation Platelets, Morii et al 1992
B lymphocytes Tominaga et al 1993
Chemoattractant-induced adhesion Lymphocytes Laudanna et al 1996
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been employed by Rozengurt and colleagues to study the actions of growth
factors and neuropeptides. In addition to inducing the reformation of stress
fibers and FAs, these agents stimulate the tyrosine phosphorylation of several
FA proteins, including FAK, paxillin, and p130cas (Zachary et al 1992, 1993,
Kumagai et al 1993, Seckl & Rozengurt 1993, Seufferlein & Rozengurt 1994,
1995). Several of these agents (LPA, bombesin, endothelin, thrombin) mediate
their effects via Rho (Ridley & Hall 1992, Jalink et al 1994, Rankin et al 1994).
These factors act on receptors that are coupled to heterotrimeric G proteins,
including G12 and G13 (Buhl et al 1995). The pathway(s) from these to Rho
have not been elucidated, although there is evidence for a tyrosine kinase (PTK)
upstream of Rho (Nobes et al 1995). Ultimately, these agents must converge to
promote the active form of Rho with GTP bound.
Like other G proteins, Rho is active when it has GTP bound. The intrinsic
GTPase activity of Rho hydrolyzes the bound GTP, rendering Rho inactive.
The cycling between the GTP-bound and GDP-bound forms is directly reg-
ulated by several proteins. For the ras family of proteins, the low intrinsic
rate of GTP hydrolysis is enhanced by GTPase-activating proteins (GAPs),
whereas the exchange of GDP for GTP is enhanced by guanine nucleotide ex-
change factors (GEFs). Guanine nucleotide dissociation inhibitors (GDIs) slow
the rate of GDP dissociation and thereby lock the G protein into the inactive
state (Hall 1994). GEFs activate G proteins, whereas GAPs will turn them off,
and GDIs maintain them in the inactive state. Several GAPs for Rho have been
identified (Ridley 1995). The first, rhoGAP, has a higher activity for cdc42 (Ri-
dley et al 1993). A second GAP for Rho, p190 (Lancaster et al 1994), prevents
the formation of stress fibers and FAs when microinjected into cells (Ridley
et al 1993). Recently, another form of p190 was discovered (Burbelo et al
1995). An unconventional myosin has been described with rhoGAP activity in
the tail domain (J Reinhard et al 1995). One GEF for Rho is the product of the
Dbl oncogene. The region of Dbl responsible for GEF activity (Dbl homology
domain) has been identified in several other proteins including Vav, Ect2, Lbc,
Ost, Tim, and Tiam (Ridley 1995), some of which may have GEF activity for
Rho or other Rho family members. A rhoGDI has been identified that acts on
Rho, Rac, and cdc42. Introduction of rhoGDI into cells inhibits both Rho- and
rac-dependent reorganization of actin (Nishiyama et al 1994). The regulation of
Rho and related proteins is clearly complex. Adding to this complexity is evi-
dence that various members of the ras superfamily may interact via their GAPs,
GEFs, and GDIs. For example, p120 RasGAP interacts with p190 RhoGAP
(Settleman et al 1992). Much remains to be learned about the interplay of ras
family regulatory proteins.
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Downstream Targets of Rho
Several potential targets for Rho have been identified. Cell adhesion regulates
the level of PIP2. Cells put into suspension demonstrate decreased levels of
PIP2. This limits the response of suspended cells to growth factors that exert
their growth stimulating effects via PIP2 hydrolysis (McNamee et al 1993). PIP2
synthesis from its precursor PIP, catalyzed by PIP 5-kinase, is stimulated by
activated Rho (Chong et al 1994), and recently an interaction between Rho and
one PIP 5-kinase isoform has been identified (Ren et al 1996, Kimura et al 1996).
PIP2 acts on several cytoskeletal proteins, promoting actin polymerization and
enhancing FA formation (see below).
By analogy with ras, which activates the raf/MEK/MAP kinase pathway
(Vojtek & Cooper 1995), it was expected that Rho would initiate a kinase cas-
cade. The Rho family members, Rac and cdc42, have been shown to activate
kinase pathways that parallel the ras/MAP kinase pathway (Coso et al 1995,
Minden et al 1995). In addition, Rho was shown to activate one of the end-
points of these Rac and cdc42 pathways (Hill et al 1995). During the past year,
two distinct serine/threonine protein kinases that interact with Rho have been
identified by several groups. The first was detected initially using GTP-Rho to
screen a rat brain expression library (Leung et al 1995). The sequence of this
Rho-binding kinase (ROK) appears to be the truncated form of a bovine brain
kinase (Rho-kinase) retained on a GST-Rho affinity column (Matsui et al 1996).
A similar kinase was isolated from human platelets using labeled GTP-Rho in
ligand overlay assays, cloned and given the name p160ROCK (Rho-associated,
coiled-coiled-containing protein kinase) (Ishizaki et al 1996). P160ROCK has
significant sequence homology with ROK/Rho-kinase with the differences
possibly reflecting tissue isoforms or species variation. This family of kinases
shares homology particularly in its kinase domain with the myotonic dystrophy
kinase. Experiments with the purified Rho-kinase indicate that it has little if
any kinase activity for many cytoskeletal proteins, with the striking exception
of the myosin-binding subunit of the myosin phosphatase (Matsui et al 1996,
Kimura et al 1996). As discussed below, this suggests an important link be-
tween Rho pathways and contractility, because phosphorylation of this subunit
of the myosin phosphatase inhibits the phosphatase activity (Trinkle-Mulcahy
et al 1995, Ichikawa et al 1996, Kimura et al 1996). A different serine/threonine
protein kinase, PKN, that interacts with Rho was also identified by two of the
above groups (Watanabe et al 1996, Amano et al 1996). In addition, the yeast
two-hybrid system was used to identify rhophilin, a protein sharing homology
with PKN but lacking kinase activity (Watanabe et al 1995). The discovery
of these Rho-stimulated serine/threonine kinases is exciting. Each may be the
first step in distinct kinase cascades initiated by activated Rho.
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Rho may also regulate the affinity of certain integrins for their ligands. Some
integrins require activation for binding to their ligands, a phenomenon known
as inside-out signaling (for details, see Ginsberg et al 1993, Schwartz et al
1995). The platelet integrin IIb3 is held in an inactive conformation until
platelets are stimulated by thrombin or other agents that trigger blood clot
formation. Following platelet stimulation, activation of IIb3 is a late event
leading to platelet aggregation. This is blocked by the C3 exotransferase (Morii
et al 1992). The inhibition of platelet aggregation by C3 may reflect rho’s
action on the cytoskeleton, or on the activation of IIb3 because both are
involved in platelet aggregation. Members of the leukocyte 2 integrin family
similarly require activation. Cell adhesion by L2 is blocked by C3 (Tominaga
et al 1993). This inhibition differs from the effects of cytochalasin, indicating
that the action of Rho cannot be accounted for simply by its effects on the
cytoskeleton and suggesting direct effects on integrin activation. The use of
C3 has implicated Rho in the activation of 1 and 2 integrins in response
to chemoattractants (Laudanna et al 1996). The original observations that C3
causes rounding up of cells are also consistent with C3 decreasing adhesion by
blocking an effect of Rho on integrins (Chardin et al 1989, Paterson et al 1990).
Together, these results suggest that Rho may activate integrins, increasing their
interaction with ECM ligands, although the mechanism is far from clear.
Rho and Contractility
Rho is a potent stimulator of stress fibers and focal adhesions. As discussed
earlier, contractility and isometric tension also contribute to stress fiber and FA
formation. This leads to the question: Does Rho induce formation of these
structures by stimulating contractility? Several lines of evidence support this
idea. Many of the agents that activate Rho, such as LPA, endothelin, bombesin,
and thrombin, are vasoconstrictors, which stimulate smooth muscle contrac-
tion. Direct evidence for an effect of Rho on contraction comes from studies
with permeabilized smooth muscle. In this system, introduction of activated
Rho enhances contractility at given calcium concentrations and lowers the cal-
cium requirement for contractility (Hirata et al 1992). Rho has been implicated
in several other contractile events (Table 3). For example, microinjection of
C3 inhibits the development of the contractile ring, a transient bundle of mi-
crofilaments responsible for generating the cleavage furrow and cytokinesis
(Mabuchi et al 1993, Kishi et al 1993). Some Rho-activating agents appear to
stimulate contraction of cells other than smooth muscle. For example, thrombin
stimulates neurite retraction (Jalink & Moolenaar 1992, Suidan et al 1992) and
induces contraction of fibroblasts and endothelial cells (Giuliano & Taylor 1990,
Goeckeler & Wysolmerski 1995). LPA stimulates contraction of chicken em-
bryo fibroblasts and human endothelial cells (Kolodney & Elson 1993), as well
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as neurite retraction (Jalink et al 1994). The contractions induced by LPA and
thrombin are Rho-mediated based on their inhibition by C3 (Jalink et al 1994).
Induction of stress fibers and FAs by LPA treatment of quiescent Balb/c 3T3
cells is accompanied by an increase in contractility (Chrzanowska-Wodnicka &
Burridge 1996). Several agents that inhibit actin-myosin interaction block the
LPA-induced formation of stress fibers and FAs, and inhibit the LPA-stimulated
tyrosine phosphorylation of FA components. These inhibitors also block FA
and stress fiber assembly induced by microinjected Rho, indicating that con-
tractility is downstream of Rho in the LPA pathway (Chrzanowska-Wodnicka
& Burridge 1996).
How might Rho stimulate contractility? LPA and thrombin stimulate MLC
phosphorylation (Kolodney & Elson 1993, Goeckeler & Wysolmerski 1995,
Chrzanowska-Wodnicka & Burridge 1996). This increase in MLC phospho-
rylation appears to precede the appearance of stress fibers and FAs, which
suggests that it is an early event in the assembly of these structures rather than
a consequence of their formation (Chrzanowska-Wodnicka & Burridge 1996).
MLC phosphorylation could result from stimulation of MLCK or inhibition of
the MLC phosphatase. Several studies on smooth muscle point to an inhibi-
tion of phosphatase activity by Rho. In smooth muscle, it has been known for
some time that excitatory agonists stimulate higher MLC phosphorylation than
that induced by KCl depolarization, suggesting that these agonists potentiate
phosphorylation not only by elevating intracellular calcium, but also by an ad-
ditional mechanism (Somlyo & Somlyo 1994). Using permeabilized smooth
muscle preparations, MLC phosphorylation and contractility are enhanced at
fixed calcium concentrations by GTPγS, which suggests the involvement of a
G protein (Kitazawa et al 1991). In this system, GTPγS inhibits MLC dephos-
phorylation, consistent with inhibition of a phosphatase (Kitazawa et al 1991).
C3 blocks the GTPγS-enhanced phosphorylation of MLCs, implicating Rho in
this process (Noda et al 1995). In addition, C3 promotes the dephosphorylation
of MLCs in permeabilized smooth muscle, further suggesting that Rho inhibits
the MLC phosphatase (Noda et al 1995).
Two recent observations suggest a pathway by which Rho may inactivate the
MLC phosphatase (mPP). First, there is the discovery that phosphorylation of
the 130-kDa-subunit of mPP inhibits its activity (Trinkle-Mulcahy et al 1995,
Ichikawa et al 1996, Kimura et al 1996). Second, there is the identification
of the Rho-stimulated serine/threonine kinases (Leung et al 1995, Amano et al
1996, Watanabe et al 1996, Ishizaki et al 1996, Matsui et al 1996). One of these,
Rho-kinase, phosphorylates the 130-kDa subunit of mPP in vitro (Matsui et al
1996, Kimura et al 1996). It will be important to establish whether Rho-kinase
alone or a Rho-activated kinase cascade is involved in the inactivation of mPP in
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vivo. Potential pathways by which Rho may regulate MLC phosphorylation and
other cytoskeletal events such as actin polymerization are indicated in Figure 3.
A MODEL FOR FOCAL ADHESION ASSEMBLY
Based on the observations discussed above, we have proposed a model for
how contractility can promote the assembly of FAs (Figure 4) (Chrzanowska-
Wodnicka & Burridge 1996). In this model, cells in suspension have integrins
dispersed over the cell surface (A). Clustering the integrins with antibodies
(B) coclusters FAK and stimulates tyrosine phosphorylation. In the absence
of ligand binding, the integrins are not associated with actin filaments. Cells
adhering to ECM via integrins are shown in panels C and D. In C, the cells
are quiescent. The integrins mediating adhesion to the underlying ECM are
distributed over the ventral surface and are not clustered into FAs. However,
because the integrins are bound to their ECM ligands, they are coupled physi-
cally to actin microfilaments via proteins such as talin or -actinin. The actin
filaments associated with these integrins are under little or no tension, because
the myosin II is in its inactive conformation. In D, the cells have been stim-
ulated to contract by agents that activate Rho. Rho activation leads to MLC
phosphorylation. This turns on myosin function and also possibly induces a
conformational change in the myosin, promoting myosin filament assembly.
The resulting force generation will align the actin filaments. Alignment will
also be promoted by the bundling action of the myosin filaments, which are very
effective at cross-linking F-actin. The tension generated will be transmitted to
the integrins in the membrane, leading to their aggregation. This clustering
of integrins is a cornerstone in the assembly of FAs. Certainly, clustering of
integrins from the outside, in combination with ligand occupancy, induces colo-
calization of many FA proteins (Miyamoto et al 1995a,b). In earlier models, it
was assumed that simply plating cells on ECM proteins leads to the clustering
of integrins in FAs. However, this does not occur if Rho is inactive (Hotchin
& Hall 1995), which implies that the clustering is driven in some way from
the inside rather than from interactions with the ECM on the outside. We have
noted that integrins mediating adhesion will aggregate into FAs when contrac-
tility is stimulated and, conversely, will disperse from FAs when contractility
is inhibited (Chrzanowska-Wodnicka & Burridge 1996). The generally low
affinity of integrins for their ECM ligands (Hynes 1992) should result in rela-
tively rapid rates of dissociation. These will permit remodeling of integrin-ECM
interactions in response to tension.
In the formation of FAs induced by activated Rho, we envisage a coopera-
tivity between the clustering of integrins driven by contractility and the effects
of elevated PIP2 (Figure 3). Activated Rho stimulates PIP 5-kinase (Chong
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Figure 3 Pathways by which Rho regulates the actin cytoskeleton. Activation of Rho by growth
factors, peptides, or adhesion is proposed to regulate the organization of the actin cytoskeleton
via two synergistic pathways. In one, MLC phosphorylation is elevated via a kinase cascade that
inhibits the myosin phosphatase (mPP). Stimulation of the MLCK (dotted line) may also occur,
but there is no evidence for this. Light chain phosphorylation stimulates contractility. In turn,
this leads to the bundling of actin filaments into stress fibers and clustering of integrins into focal
adhesions. In the second, complementary pathway, Rho stimulates PIP 5-kinase, elevating PIP2
levels. PIP2 dissociates gelsolin and profilin from actin, promoting actin polymerization. PIP2 also
binds to vinculin, causing a conformational change that exposes binding sites for talin and actin,
enhancing focal adhesion assembly.
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Figure 4 Model for contraction-induced formation of focal adhesions and stress fibers. In sus-
pended cells (A), integrins are dispersed over the cell surface and not attached to actin filaments.
Integrins can be clustered from the outside with antibodies (B), inducing FAK phosphorylation, but
not attachment to actin, without ligand binding to the integrins. Adherent cells are shown in (C)
and (D). Their integrins are bound to ECM ligands and because of this ligand occupancy become
attached to actin filaments. However, in (C) the cells are quiescent, Rho is inactive, and the myosin
is in the nonfunctional conformation. In (D) Rho activation stimulates contractility by elevating
MLC phosphorylation. This leads to myosin filament formation and a force-generating interaction
with actin. The tension exerted on the actin filaments bundles them into stress fibers and clusters
the integrins to which they are attached. In turn, the integrin clustering stimulates FAK activity,
triggering the signaling events associated with tyrosine phosphorylation in FAs.
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et al 1994) and elevated PIP2 stimulates dissociation of both profilin and gel-
solin from actin, thereby promoting actin polymerization (Lassing & Lindberg
1985, Janmey & Stossel 1987). In addition, PIP2 affects the conformation of
vinculin, dissociating the intramolecular head/tail interaction, thereby expos-
ing the talin- and actin-binding sites (Gilmore & Burridge 1996). PIP2 has
also been reported to enhance the binding of -actinin to actin (Fukami et al
1992). Together these actions enhance stress fiber and FA formation. Inhibit-
ing either side of the pathway illustrated in Figure 3 prevents assembly of FAs.
Sequestering PIP2 by microinjection of antibodies against PIP2 into quiescent
cells blocks the formation of FAs and stress fibers induced by Rho (Gilmore
& Burridge 1996). Similarly, blocking contractility by a variety of agents with
different modes of action inhibits the Rho-mediated assembly of stress fibers
and FAs (Chrzanowska-Wodnicka & Burridge 1996).
FA assembly is accompanied by recruitment of signaling components. Evi-
dence has been presented that this recruitment depends on tyrosine phosphory-
lation (Miyamoto et al 1995b). Signaling in FAs is further discussed below, but
some points are relevant here in the context of assembly. One of the most promi-
nent signaling events within FAs is the tyrosine phosphorylation that involves
FAK. FAK may associate directly or indirectly with integrins and becomes
activated as a result of integrin aggregation (Kornberg et al 1991, Miyamoto
et al 1995a). The model predicts that anything promoting contractility and the
consequent aggregation of integrins will stimulate FAK activation (if FAK is
associated with the clustered integrins), which provides an explanation for the
stimulation of FAK by the diverse group of agents that act via Rho. It is gen-
erally envisaged that autophosphorylation of FAK recruits src family kinases
that, in turn, phosphorylate other components, generating binding sites for sig-
naling proteins with SH2 domains. A multicomponent signaling complex is
assembled that depends on the initial activation of FAK (Schaller & Parsons
1994, 1995, Miyamoto et al 1995b, Yamada & Miyamoto 1995, Richardson &
Parsons 1995, Schwartz et al 1995). A surprising but consistent observation
has been that disruption of the actin cytoskeleton, for example by treatment
with cytochalasin D, inhibits the phosphorylation of FAK (Pelletier et al 1992,
Haimovich et al 1993, Bockholt & Burridge 1993, Sinnett-Smith et al 1993,
Seufferlein & Rozengurt 1994, Shattil et al 1994) as well as various downstream
signaling events (Chen et al 1994). In the proposed model, FAK activation
depends on the clustering of integrins from the inside by contractility. Disrup-
tion of the actin cytoskeleton would consequently block integrin aggregation
driven by contractility and would account for the inhibition of FAK activity.
Similarly, the model offers a potential explanation for the biphasic effects of
PDGF on FAK phosphorylation. At low concentrations, PDGF stimulates FAK
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phosphorylation, but at higher concentrations it disrupts stress fibers and FAK
phosphorylation is inhibited (Rankin & Rozengurt 1994).
This model also offers an explanation for the observation that cells could
spread on a low density of integrin ligand but required higher densities in order
to form FAs (Massia & Hubbell 1991). At low-ligand density, clustering the
integrins would result in their dissociation from ligand. In the absence of bound
extracellular ligands, the integrins would likely detach from the cytoskeleton.
Therefore, a sufficiently high density of ligand on the substrate would be needed
for the aggregated integrins to remain bound.
Does this model for FA formation also account for their assembly as sus-
pended cells are plated on an ECM or during cell migration? We suspect that
many aspects of the model are still relevant. Evidence shows that active Rho
is required for the formation of FAs when cells are plated on ECM substrates
(Hotchin & Hall 1995). FAs appear to form spontaneously when many cells
are plated on ECM, but for most cells, Rho remains in an active state for several
hours even in the absence of serum. When cells are plated on ECM substrates,
inhibitors of contractility block the formation of FAs or result in very small
FAs that appear not to have matured into their normal organizational state (M
Chrzanowska-Wodnicka & K Burridge, unpublished observations). These re-
sults are consistent with a Rho-mediated contractile event contributing to the
formation of FAs in cells spreading on ECM proteins.
Tyrosine Phosphorylation and Focal Adhesion Assembly
Several studies have shown that PTK inhibitors block the formation of FAs and
stress fibers induced either by adhesion to an ECM-coated surface (Burridge
et al 1992, Romer et al 1992, 1994) or by Rho activation (Seckl & Rozengurt
1993, Chrzanowska-Wodnicka & Burridge 1994, Ridley & Hall 1994). Be-
cause the major sites of tyrosine phosphorylation in cultured fibroblasts are
FAs and because these inhibitors decrease the tyrosine phosphorylation of FA
proteins such as FAK and paxillin, the interpretation of these data was that ty-
rosine phosphorylation of FA components contributes to the assembly of these
structures (Burridge et al 1992, Romer et al 1994). However, several lines of
evidence indicate that neither the kinase inhibited in these studies nor its sub-
strates reside in FAs. Wilson and coworkers provided evidence that FAK is not
required for the formation of FAs in vascular smooth muscle cells (Wilson et al
1995). Similarly, when transformation by temperature-sensitive mutants of v-
src was shut off, FAs reassembled in the absence of tyrosine-phosphorylated
FAK or paxillin (Fincham et al 1995). Cells from FAK− mice reveal prominent
FAs that contain phosphotyrosine (Ilic et al 1995). Because FAK appears to be
the major PTK in FAs in normal cells, this result is unexpected. In the absence
of FAK, possibly other kinases are recruited to these structures, or the level or
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activity of src family kinases in FAs may increase. Alternatively, a homologue
of FAK, such as CAK/PYK2/RAFTK (Avraham et al 1995, Lev et al 1995,
Sasaki et al 1995) may be expressed in these cells, partially compensating for
the lack of FAK. If there is compensation by another kinase, it is incomplete
because FAK− mice die as embryos (Ilic et al 1995). The prominent phos-
photyrosine in the FAs of the FAK− cells differs from results obtained using
microinjection of a C-terminal FAK construct that contains the FAT sequence
but lacks the kinase domain (Gilmore & Romer 1996). This FAK construct
displaces endogenous FAK from FAs and abolishes detectable phosphotyro-
sine at these sites. Significantly, FAs can still be assembled in these cells, but
they lack detectable FAK and phosphotyrosine. These experiments suggest that
FAK is not required for FA assembly or maintenance, although it appears to be
important for other signaling pathways (Gilmore & Romer 1996).
Inhibition of FAK tyrosine phosphorylation has also been observed in cells
overexpressing pp41/43FRNK (FRNK), the naturally expressed C-terminal do-
main of FAK, which lacks the kinase domain (Richardson & Parsons 1996).
Overexpression of FRNK also diminished the tyrosine phosphorylation of pax-
illin and tensin. These cells could still form focal adhesions but at a slower rate.
Cell spreading on a fibronectin substrate was significantly retarded (Richardson
& Parsons 1996).
These lines of evidence indicate that although tyrosine phosphorylation and
FAK activity recruit signaling components to FAs, FAK does not have a role
in the assembly of the structural components. If this is the case, where do the
PTK inhibitors act to block the formation of FAs and stress fibers? Evidence
indicates that they act both upstream and downstream of Rho activation (Ridley
& Hall 1994, Chrzanowska-Wodnicka & Burridge 1994, Nobes et al 1995). In
the model proposed for FA assembly (Figure 3), Rho initiates a kinase cascade
that results in MLC phosphorylation, thereby stimulating contractility. We
suspect that one of the kinases regulating contractility may be blocked by PTK
inhibitors. Alternatively, a tyrosine kinase may be involved in Rho-stimulated
PIP2 synthesis.
SIGNALING IN FOCAL ADHESIONS
Integrin-mediated cell adhesion triggers tyrosine phosphorylation, ion fluxes,
and lipid metabolism (Clark & Brugge 1995, Schwartz et al 1995). Together or
individually, these affect many downstream pathways, influencing events such
as gene expression, progression through the cell cycle, and apoptosis. Some of
the integrin-mediated signal transduction pathways, such as tyrosine phospho-
rylation, have been shown to be initiated from FAs, whereas others may precede
FA formation and be early responses to integrin occupancy or clustering. The
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Table 4 Signaling proteins at the cytoplasmic face of focal adhesions
Tyrosine kinases Heterotrimeric G proteins Proteases
1. FAK 6. γ 5 10. calpain II
2. src
3. csk Adapters Others
4. fyn 7. paxillin 11. PI3K
8. p130cas 12. LIP1
9. Grb2
Serine kinases
5. PKC ; 
1. Schaller et al 1992; 2. Kaplan et al 1994; 3. Bergman et al 1995; 4. included
because of its interaction with FAK; Cobb et al 1994; 5. Jaken et al 1989,
Barry & Critchley 1994; 6. Hansen et al 1994; 7. Turner et al 1990; 8. Petch
et al 1995; 9. M Kinch, unpublished observation; 10. Beckerle et al 1987; 11.
Geiger et al 1992a; 12. Serra-Pages et al 1995.
idea that FAs are major sites of signal transduction is supported by the identifi-
cation of multiple signaling proteins in FAs (Table 4). Numerous interactions
occur between these and other signaling components involved in receptor PTK
signaling pathways (Table 5). Using beads coated with antibodies or integrin
ligands, Miyamoto and colleagues have identified a striking list of signaling
proteins that associate with clustered integrins in a tyrosine phosphorylation-
dependent manner (Miyamoto et al 1995b). Many have not been seen in FAs,
but the bead technique may allow easier visualization of components that asso-
ciate transiently with integrins. Alternatively, some of these components may
be involved with endocytosis, a process also dependent on tyrosine phospho-
rylation (Shimo et al 1993, Salamero et al 1995). In the following discussion,
we concentrate on signaling involving tyrosine phosphorylation.
Tyrosine Phosphorylation
Early work on tyrosine phosphorylation in FAs has been reviewed (Burridge
et al 1988). A link between integrins and tyrosine phosphorylation was first
demonstrated in platelets, where thrombin was shown to trigger tyrosine phos-
phorylation in an integrin-dependent fashion (Ferrell & Martin 1989, Golden
& Brugge 1989). These observations were followed by studies with cells in
culture, where it was also shown that integrin clustering or integrin-mediated
adhesion stimulate tyrosine phosphorylation of a small set of proteins (Guan
et al 1991, Kornberg et al 1991, Burridge et al 1992). Coincident with these
studies was the discovery of a cytoplasmic PTK that localizes to FAs, the FA ki-
nase (pp125FAK or FAK) (Schaller et al 1992, Hanks et al 1992). The discovery
of FAK galvanized the field, and FAK was shown to be the most prominent of
the tyrosine-phosphorylated proteins in cells responding to integrin clustering
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or integrin-mediated adhesion (Burridge et al 1992, Hanks et al 1992, Guan &
Shalloway 1992, Kornberg et al 1992, Lipfert et al 1992). Several other FA
proteins were identified as also becoming tyrosine-phosphorylated in response
to integrin-mediated adhesion. These included paxillin (Burridge et al 1992),
tensin (Bockholt & Burridge 1993), PI 3-kinase (Chen & Guan 1994a), and
p130cas (Petch et al 1995, Vuori & Ruoslahti 1995, Nojima et al 1995). No-
tably, the more major proteins in FAs—talin, vinculin, integrins—contain little
or no phosphotyrosine. This contrasts with the situation in src-transformed
cells in which low levels of phosphotyrosine are detected in these proteins.
FAK is a cytoplasmic PTK with three domains. The central catalytic domain
separates an N-terminal domain, shown to bind to 1 integrin cytoplasmic
domain peptides (Schaller et al 1995), and a C-terminal domain, which contains
a FA-targeting (FAT) sequence (Hildebrand et al 1993). This latter domain
contains binding sites for at least two FA proteins, paxillin and talin (Turner
& Miller 1994, Chen et al 1995, Hildebrand et al 1995, Tachibana et al 1995).
Lewis & Schwartz (1995) found that association of FAK with clustered integrins
in vivo depended on the most C-terminal 13 residues of the 1 cytoplasmic
domain. This was also the sequence required for co-clustering talin and paxillin
with integrins, possibly indicating that one or other might contribute to FA
targeting. In addition, FAK constructs containing the paxillin-binding sequence
target to FAs, but fail to do so if this binding sequence is disrupted (Tachibana
et al 1995). In these experiments, the interaction with talin was not examined,
but it might also contribute to targeting FAK to FAs. These results support
the idea that the interaction of FAK with paxillin or talin targets it to FAs.
However, Miyamoto and colleagues found that simple aggregation of integrins
was sufficient to co-cluster FAK but not talin or paxillin (Miyamoto et al 1995a).
Co-clustering of talin required both aggregation and ligand occupancy, whereas
co-clustering of paxillin required tyrosine phosphorylation as well.
The significance of the interaction of the N-terminal domain with integrin
peptides is not obvious because this region does not appear to be involved in
targeting FAK to FAs. Possibly this interaction functions in the activation of
FAK, but most of the evidence indicates that clustering of integrins triggers FAK
activation (Kornberg et al 1991, Defilippi et al 1994) and that ligand occupancy
is not involved (Miyamoto et al 1995a). However, clustering of one integrin
with an activating antibody failed to induce tyrosine phosphorylation (Pelletier
et al 1995). Integrin aggregation may dimerize FAK, and thereby stimulate
transphosphorylation and activation. This would be consistent with the model
for activation of receptor PTKs (Ullrich & Schlessinger 1990).
For many receptor PTKs, ligand binding triggers autophosphorylation. The
resulting phosphotyrosines in the receptor cytoplasmic domain bind SH2
A
nn
u.
 R
ev
. C
el
l D
ev
. B
io
l. 
19
96
.1
2:
46
3-
51
9.
 D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
 
A
cc
es
s p
ro
vi
de
d 
by
 U
ni
ve
rs
ity
 o
f N
or
th
 C
ar
ol
in
a 
- C
ha
pe
l H
ill
 o
n 
05
/0
2/
18
. F
or
 p
er
so
na
l u
se
 o
nl
y.
 
      
September 14, 1996 12:5 Annual Reviews BURRCHPT.DUN AR018-16
494 BURRIDGE & CHRZANOWSKA-WODNICKA
domain-containing proteins. A similar situation is found for FAK. Several sites
of tyrosine phosphorylation have been identified that recruit specific proteins
via their SH2 domains (Schaller et al 1994, Schlaepfer et al 1994). The ma-
jor site of tyrosine phosphorylation in FAK is Tyr-397, which arises through
autophosphorylation (Schaller et al 1994). This generates a binding site for
the SH2 domains of pp60src and pp59fyn, both of which have been shown to
complex with FAK in cells (Cobb et al 1994, Schlaepfer et al 1994, Xing
et al 1994). These kinases phosphorylate additional sites in FAK and may
stimulate FAK activity (Schlaepfer et al 1994, Calalb et al 1995). One of
these sites, Tyr-925, complexes with the adapter protein Grb2 (Schlaepfer et
al 1994). In normal cells, the association of Grb2 with FAK is dependent on
integrin-mediated adhesion, but in v-src-transformed cells, FAK is constitu-
tively tyrosine-phosphorylated and bound to Grb2. In these src-transformed
cells, Grb2 is further associated with Sos, a Ras GTP/GDP exchange factor
that activates the MAP kinase pathway (Schlaepfer et al 1994). This pathway
may also operate in normal cells because MAP kinase activation has been ob-
served in cells plated onto fibronectin in the absence of growth factors (Chen
et al 1994, Schlaepfer et al 1994, Morino et al 1995, Zhu & Assoian 1995),
and antibody-clustering of 21 integrins in lymphocytes elevates the level of
Ras-GTP (Kapron-Bras et al 1993). However, MAP kinase activation may be
triggered by other signaling cascades initiated by integrin-mediated adhesion.
The association of pp60src and pp59fyn with FAK raises the question of which
PTK is responsible for the tyrosine phosphorylation of specific FA proteins.
Examining cells from transgenic mice that had had their src, fyn, or yes genes
individually knocked out revealed that the patterns of tyrosine phosphorylation
upon adhesion to fibronectin resembled that in control cells, with the exception
of p130cas (Bockholt & Burridge 1995). The tyrosine phosphorylation level of
p130cas was reduced in the fyn− and yes− cells, and to a particularly low level
in the src− cells, suggesting that its phosphorylation is dependent on src and to
a lesser extent on the other src family kinases. Although many of their charac-
teristics resemble normal cells, the src− cells spread more slowly on fibronectin
(Kaplan et al 1995). Besides FAK, one of the major tyrosine-phosphorylated
proteins in FAs is paxillin (Turner 1994). Paxillin binds FAK and is a substrate
for FAK in vitro and in vivo (Bellis et al 1995, Hildebrand et al 1995, Schaller
& Parsons 1995). Autophosphorylation of FAK on Tyr-397 is required for
paxillin phosphorylation (Schaller & Parsons 1995), which suggests that src or
fyn may be involved, given that these two kinases bind to this site. Paxillin is
a substrate in vitro not only for FAK, but also for src and csk (the kinase that
regulates src activity by phosphorylation of its C-terminal tyrosine) (Schaller
& Parsons 1995). All three kinases phosphorylate sites in vitro that are also
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phosphorylated in vivo (Schaller & Parsons 1995). These authors suggest a
model whereby cell adhesion results in FAK autophosphorylation. This phos-
phorylation recruits src/fyn or csk by binding to the SH2 domains of these
kinases. In turn, these phosphorylate paxillin on multiple sites. The absence
of an obvious decrease in paxillin tyrosine phosphorylation in the src− cells
may reflect redundancy in the system with fyn or csk replacing src (Bockholt
& Burridge 1995).
Csk is an important regulator of the src family kinases. It inhibits their activity
by phosphorylating the C-terminal tyrosine residue. This C-terminal phospho-
tyrosine then participates in an intramolecular association with its own SH2
domain, leading to a steric inhibition of the kinase domain (Cooper & Howell
1993). Overexpression of csk leads to its detection within FAs (Bergman et al
1995), suggesting that it is normally present but below the level of detection.
Deletion of Csk results in src that is not phosphorylated on its C-terminal tyro-
sine (Tyr-527), and src now becomes detected in focal adhesions (Kaplan et al
1994). Similarly, mutating tyr-527 to phenylalanine, which prevents phospho-
rylation, results in src becoming prominently associated with FAs. Interest-
ingly, the targeting of src to FAs occurs in the absence of the kinase domain
and requires an intact SH3 domain (Kaplan et al 1994). The SH3 domain has
been shown previously to bind to paxillin (Weng et al 1993). This may be the
interaction that targets src to FAs, whereas the src SH2 interaction with FAK
may activate src by displacing the intramolecular association between the SH2
domain and Tyr-527. A src construct lacking the kinase domain, but with intact
SH2 and SH3 domains, elevates phosphotyrosine in FAs, particularly in FAK
(Kaplan et al 1994). The mechanism for this is uncertain, but it may reflect
the src SH2 domain protecting tyrosine-phosphorylated residues from tyrosine
phosphatases. In csk− cells the level of phosphotyrosine in paxillin is increased,
consistent with src family kinases being responsible (Nada et al 1994, Thomas
et al 1995). The relationship of src and fyn has been investigated in the csk−
background using double knockouts (Thomas et al 1995). These authors ob-
served a decrease in the total level of phosphotyrosine in the src−csk− cells
but not the fyn−csk− cells, suggesting that src is more critical than fyn to the
elevation of phosphotyrosine in the csk− cells. However, the elevated phos-
photyrosine in paxillin was partially decreased by the introduction of either
the src− or fyn− mutation, consistent with both these kinases having a role in
phosphorylating paxillin.
Another major tyrosine-phosphorylated protein in FAs is p130cas (Petch et al
1995). The data from the src− cells suggest that much of the tyrosine phos-
phorylation of this protein is also from the activity of src (Bockholt & Burridge
1995). Like paxillin, this is a protein that interacts with other signaling proteins
A
nn
u.
 R
ev
. C
el
l D
ev
. B
io
l. 
19
96
.1
2:
46
3-
51
9.
 D
ow
nl
oa
de
d 
fro
m
 w
w
w
.an
nu
al
re
vi
ew
s.o
rg
 
A
cc
es
s p
ro
vi
de
d 
by
 U
ni
ve
rs
ity
 o
f N
or
th
 C
ar
ol
in
a 
- C
ha
pe
l H
ill
 o
n 
05
/0
2/
18
. F
or
 p
er
so
na
l u
se
 o
nl
y.
 
    
September 14, 1996 12:5 Annual Reviews BURRCHPT.DUN AR018-16
496 BURRIDGE & CHRZANOWSKA-WODNICKA
(Table 5). The sequence of p130cas reveals that it contains one SH3 domain and
numerous tyrosines within the consensus-binding sites for the SH2 domains
of src and crk (Sakai et al 1994). Both paxillin and p130cas bind the adapter
protein crk, which consists of SH2 and SH3 domains (Birge et al 1992, 1993,
Schaller & Parsons 1995). The latter mediates interaction with two guanine
nucleotide exchange factors for ras, Sos and C3G (Matsuda et al 1994, Tanaka
et al 1994). The multiple interactions of paxillin and p130cas with other signal-
ing proteins has led to the general view that these proteins may be equivalent
to the IRS-1 protein in insulin-signaling pathways. IRS-1 becomes tyrosine-
phosphorylated on multiple sites in response to insulin binding to the insulin
receptor. This provides a scaffold for downstream signaling components to
bind via their SH2 domains. Similarly, following their tyrosine phosphoryla-
tion, paxillin and p130cas may also act as scaffolds, recruiting other signaling
proteins into a complex that activates separate or overlapping signaling path-
ways.
Very little is known about tyrosine phosphatases (PTPs) in FAs. The trans-
membrane PTP, LAR has been detected in the FAs of some cells, together with
an interacting cytoplasmic protein, LIP (Serra-Pages et al 1995). However, in
several cell types LAR has not been detectable in FAs, indicating that other
PTPs may be present (G Schneider & K Burridge, unpublished observations).
Does Integrin-Mediated Adhesion Activate Rho?
The formation of stress fibers and FAs requires activated Rho (Ridley & Hall
1992). Cells plated on an ECM in the absence of growth factors also de-
velop FAs, raising the possibility that integrin-mediated adhesion activates
Rho, thus providing the stimulus for FA formation. Supporting this idea
was the demonstration that PIP2 levels increase when cells adhere to ECM
McNamee et al 1993) and that this depended on Rho (Chong et al 1994). These
results indicate that integrin engagement activates Rho. However, this has been
challenged by the experiments of Hotchin & Hall (1995), who found that quies-
cent cells, with low levels of active Rho failed to form FAs or stress fibers when
plated on fibronectin substrates for 30–45 min. Under these conditions, FAs
formed rapidly upon Rho activation. Similar experiments were performed by
Barry and coworkers who also observed a failure to form FAs and stress fibers
30 min after plating quiescent cells on fibronectin (Barry et al 1996). However,
in this study FAs and stress fibers were seen 3 h after adhesion to fibronectin,
indicating that this interaction does activate Rho, albeit inefficiently or with a
delayed time course.
The activation of Rho in response to integrin-mediated adhesion may involve
an arachidonic acid/leukotriene pathway. The spreading of cells on ECM sub-
strates stimulates and requires activation of PKC (Chun & Jacobson 1992, 1993,
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Vuori & Ruoslahti 1993) and release of arachidonic acid (Chun & Jacobson
1992). Blocking the metabolism of arachidonic acid to leukotrienes prevents
HeLa cells spreading on a collagen matrix, and this block can be partially over-
come by added leukotrienes (Chun & Jacobson 1992). Notably, leukotrienes
have been reported to stimulate Rho (Peppelenbosch et al 1995). Together these
results suggest a pathway in which leukotrienes may link integrin-mediated ad-
hesion to Rho activation. Leukotriene synthesis and stimulation of Rho also
provide a connection between Rac and Rho in cells responding to EGF (Pep-
pelenbosch et al 1995). The activation of Rac is associated with extensive
membrane ruffling (Ridley et al 1992), and this phenotype resembles the be-
havior of cells freshly plated on ECM. Indeed, the behavior of cells spreading
on ECM resembles cells responding sequentially to cdc42, Rac, and finally
Rho. Initial adhesion is associated with production of filopodia (the cdc42
phenotype) (Albrecht-Buehler 1976), followed by lamellipodia (the Rac phe-
notype) and, finally, when cells have become well spread, the development of
stress fibers and FAs (the Rho phenotype). A hierarchy has been demonstrated
previously, with cdc42 upstream of rac, which is upstream of Rho (Nobes &
Hall 1995). It is conceivable, therefore, that this is also the pathway from
integrin-mediated adhesion to activation of Rho, going via cdc42, Rac, and the
synthesis of leukotrienes.
An alternative pathway by which Rho may become activated during adhe-
sion involves Vav, a possible Rho GEF. In platelets, Vav becomes tyrosine-
phosphorylated upon platelet activation by thrombin or collagen (Cichowski
et al 1996). The stimulation by collagen occurs via the integrin 21, indicat-
ing that in some circumstances Vav regulation is integrin-dependent. Vav binds
the FA protein zyxin, contains one SH2 domain, two SH3 domains, a pleckstrin
homology domain, and a dbl homology domain. The latter is associated with
guanine nucleotide exchange. Whether Vav acts on Rho or another ras-related
protein is controversial, but the phenotype of cells transformed by Vav suggests
that it acts directly or indirectly on Rho (Khosravi-Far et al 1994). Vav is nor-
mally confined to hematopoietic cells, but a widely distributed isoform, Vav2,
has been identified (Henske et al 1995). Vav itself becomes phosphorylated
on serine and tyrosine residues and is probably involved in several signaling
cascades (Gulbins et al 1993, Uddin et al 1995, Matsuguchi et al 1995). If
Vav2 becomes phosphorylated by integrin engagement, this would suggest one
way by which adhesion might activate Rho. Because Rho enhances adhesion
and spreading, the activation of Rho by adhesion suggests a positive feedback
loop. Positive feedback loops have previously been suggested to occur during
adhesion and spreading in the context of PKC activation (Chun & Jacobson
1993).
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Focal Adhesions and Growth Control
It has been long known that most normal cells in culture are anchorage de-
pendent, i.e. they require attachment to a substrate in order to go through the
cell cycle (Stoker et al 1968). The requirement for anchorage is abolished by
many different oncogenes. Suspension of normal cells arrests not only DNA
synthesis, but also inhibits RNA and protein synthesis (Otsuka & Moskowitz
1975, Benecke et al 1978, 1980, Farmer et al 1978, Ben-Ze’ev et al 1980). Cell
cycle progression is blocked in G1 by suspension (Otsuka & Moskowitz 1975).
Clearly with normal cells, adhesion-dependent signals regulate many activi-
ties and permit cells to respond to growth factors. Several integrin-mediated
signaling pathways have been implicated. Elevated intracellular pH has been
associated with growth of normal cells, and this is regulated by integrins via
the NaC/HC antiporter (Schwartz et al 1989, 1990, 1991a,b, Ingber et al 1990).
Integrins have also been linked to elevated intracellular Ca2C (Pelletier et al
1992, Leavesley et al 1993, Schwartz et al 1993, Schwartz 1993, Schwartz
& Denninghoff 1994). In endothelial cells, the integrin-dependent elevation in
intracellular Ca2C involves an integrin-associated protein (IAP) (Schwartz et al
1993). The mechanism by which integrins elevate intracellular Ca2C has not
been resolved, but intracellular Ca2C has been associated with many mitogenic
signals and pathways. Intracellular Ca2C levels are frequently elevated by re-
lease from intracellular stores via a pathway that involves PIP2 hydrolysis and
the generation of inositol trisphosphate (IP3) (Berridge 1993). As discussed
above, PIP2 levels are elevated by adhesion in a Rho-dependent manner (Mc-
Namee et al 1993, Chong et al 1994). One pathway from growth factor receptors
involves activation of phospholipase C, which hydrolyzes PIP2 to generate IP3
and diacyl glycerol. These act as second messengers elevating intracellular
Ca2C and activating PKC. The decrease in PIP2 that occurs with suspension of
cells deprives PLC of its substrate and has been correlated with the inability of
cells in suspension to respond to growth factors, even though the growth factors
bind to their receptor PTKs (McNamee et al 1993).
Many lines of evidence point to a collaboration between the signals emanating
from FAs and growth control. For example, in collagen gels, cells show high
proliferation rates if the gel is anchored so that the cells generate isometric
tension and develop stress fibers. In contrast, cells in free-floating gels do not
develop isometric tension or stress fibers, and the cells become arrested for
DNA synthesis and proliferation (Lin & Grinnell 1993, Grinnell 1994). With
adherent cells in culture, several mitogens stimulate tyrosine phosphorylation of
the same repertoire of FA proteins (FAK, paxillin, p130cas, tensin) (Zachary et al
1992, 1993, Kumagai et al 1993, Sinnett-Smith et al 1993, Hordijk et al 1994,
Seufferlein & Rozengurt 1994). Most, if not all, of these mitogens stimulate
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Rho, contractility, and the formation of FAs in quiescent cells. Introduction of
activated Rho into quiescent cells is itself sufficient to stimulate progression
through the cell cycle and DNA synthesis (Olson et al 1995).
Adhesion to ECM activates the MAP kinase pathway, which is also triggered
by many growth factors. MAP kinase activation may be via Grb2 binding
to phosphorylated Tyr-925 in FAK (Schlaepfer et al 1994), but other adapter
proteins interact with FA proteins, such as paxillin and p130cas (Table 5) and
may provide parallel routes to MAP kinase activation. Adhesion alone is an
insufficient stimulus to activate the MAP kinase pathway if Rho is not active
(Hotchin & Hall 1995). It is not clear why growth factors and adhesion to
ECM should both stimulate MAP kinase activation. The experimental paradigm
of plating suspended cells on ECM substrates such as fibronectin is clearly
artificial. One can imagine, however, that an equivalent situation is encountered
normally when circulating cells adhere to a damaged blood vessel wall or when
cells respread after mitosis. Similarly, during migration, the formation of new
adhesions may trigger localized activation of MAP kinase pathways.
Is FAK involved in the synergy between integrin and growth factor signal-
ing? Analysis of the role of FAK in growth control has not been possible with
the FAK− cells because they were transfected with activated p53 to promote
growth (Ilic et al 1995). However, in an experimental model discussed above,
FAK function was analyzed using microinjection of a C-terminal construct to
displace endogenous FAK from FAs (Gilmore & Romer 1996). Displacement
of FAK from FAs significantly decreased the number of cells entering DNA syn-
thesis in response to stimulation with serum. This finding supports the idea that
signaling from FAK contributes to and may be necessary for normal cells to re-
spond to growth factors and to display anchorage-dependent growth. A similar
conclusion was reached in experiments where epithelial cells were transfected
with constitutively active FAK. This rendered the epithelial cells anchorage in-
dependent and even made them tumorigenic (Frisch et al 1996). In the model for
FA formation discussed above, FAK activation results from integrin clustering
induced by contractility within the microfilament system. This model predicts
that disruption of the cytoskeleton should prevent FAK activation, which would
resemble loss of adhesion in terms of growth control. This indeed is the case.
Disruption of the cytoskeleton with cytochalasin mimics the effect of cell sus-
pension, blocking cells that are anchorage dependent in G1 (Bohmer et al 1996).
Direct interactions between integrins and growth factor-signaling compo-
nents have been identified. In response to insulin stimulation, IRS-1 associates
with the vitronectin receptor, v3. Insulin stimulates growth of cells adhering
to vitronectin more effectively than it stimulates cells adhering to other ECM
proteins (Vuori & Ruoslahti 1994). The FGF receptor flg has been identified
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in FA complexes isolated on fibronectin-coated beads (Plopper et al 1995). In
addition, numerous signaling components associated with receptor PTKs also
associate with clustered integrins (Miyamoto et al 1995b).
The interplay between integrins and growth factors is illustrated by the growth
and differentiation of myoblasts. Sastry and colleagues have found that ectopic
expression of the 5 integrin subunit inhibits differentiation, promoting pro-
liferation. In contrast, ectopic expression of 6 promotes differentiation and
inhibits proliferation in this system (Sastry et al 1996). Chimeric constructs,
in which the cytoplasmic domains were truncated or swapped, demonstrated
that these effects depended on the  subunit cytoplasmic domains. The ectopic
expression of 5 changed the response of myoblasts to specific growth factors.
For example, normally both TGF and bFGF inhibit proliferation and stimu-
late differentiation, but following transfection with the 5 subunit, these growth
factors inhibited differentiation. However, only bFGF stimulated proliferation,
whereas TGF now induced apoptosis (Sastry et al 1996). Ectopic expres-
sion of 5 in other situations also affects growth characteristics. For example,
expression of 5 in tumor cells deficient in this integrin subunit has been corre-
lated with restoration of a normal phenotype and anchorage-dependent growth
(Giancotti & Ruoslahti 1990). These effects of 5 expression on tumor cell
growth are complex. Ectopic expression of 5 inhibits anchorage-independent
growth, but it promotes growth on an appropriate ECM substrate (Varner et al
1995). These findings imply that a negative growth signal is transmitted by the
unengaged 51 integrin, but a positive proliferation signal is triggered upon
ligand binding to this integrin. Clearly, different  subunits generate distinct
signals, although very little is known about their nature. Integrin cytoplasmic
domains also generate growth-related signals as evidenced by the inhibition of
cell cycle progression and proliferation induced by ectopic expression of the1C
alternatively spliced cytoplasmic isoform (Meredith et al 1995, Fornaro et al
1995). 1C has been identified in platelets, megakaryocytes, and some other
blood cells (Languino & Ruoslahti 1992). It is absent from growing endothelial
cells but is induced when endothelial cells are growth arrested by exposure to
tumor necrosis factor  (Fornaro et al 1995).
The expression of 5 integrin in transformed cells restores more normal
growth characteristics and the formation of FAs. As mentioned above, in nor-
mal cells the ability to form FAs correlates with anchorage-dependent growth,
and disruption of FAs leads to cell cycle arrest. However, a paradoxical situa-
tion is seen in cells in which the levels of vinculin or -actinin are decreased, for
example, by antisense cDNA constructs. Depressing the level of either protein
results in decreased FAs, increased motility, and anchorage-independent growth
(Rodriguez Fernandez et al 1992, 1993, Gluck et al 1993, Gluck & Ben-Ze’ev
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1994). Cells with decreased levels of vinculin or -actinin form tumors when
injected into nude mice. Moreover, several transformed cells or tumors show
decreased expression of vinculin or -actinin. Elevating the levels of these pro-
teins restores a more normal phenotype, including anchorage-dependent growth
and suppression of tumorigenicity (Gluck et al 1993, Rodriguez Fernandez et al
1992). A possible explanation for these observations relates to the fact that both
vinculin and -actinin are major PIP2-binding proteins (Fukami et al 1994).
Levels of PIP2 are reduced when normal cells are suspended, and this has been
correlated with growth arrest of cells in suspension (McNamee et al 1993). If
vinculin and -actinin are major sinks for cytoplasmic PIP2, it is conceivable
that reducing their levels increases PIP2 availability to hydrolysis by PLC and
thus permits suspended cells to respond to growth factor stimulation by PIP2
hydrolysis. It will be important to determine whether vinculin and -actinin
buffer PIP2 levels. If incorporation of vinculin and -actinin into FAs releases
their bound PIP2, this would also increase the PIP2 available for hydrolysis and
provide another link between focal adhesions and mitogenic pathways.
Apoptosis
Cooperativity between integrin-mediated adhesion and growth factors is also
seen in relation to apoptosis. Loss of adhesion blocks progression through the
cell cycle for normal anchorage-dependent cells. But more than that, for some
cells it also induces apoptosis (programmed cell death), particularly in the
absence of growth factors (Meredith et al 1993, Frisch & Francis 1994, Re et al
1994). Engagement of different integrins prevents apoptosis in different cell
types. Thus the 5 integrin subunit increases survival of CHO cells adhering
to fibronectin in the absence of growth factors (Zhang et al 1995). Similarly,
in muscle cells expressing ectopic 5, survival is increased in the presence of
bFGF, whereas untransfected cells become apoptotic (Sastry et al 1996). 1
integrins prevent apoptosis in mammary epithelial cells adhering to basement
membranes (Boudreau et al 1995). In contrast, disruption of v3 interactions
promote apoptosis in colon carcinoma cells, endothelial cells, and melanoma
cells (Bates et al 1994, Brooks et al 1994, Montgomery et al 1994). The term
anoikis (Greek for homelessness) has been coined to describe the apoptosis that
results from loss of normal adhesion to ECM (Frisch & Francis 1994).
Is there a role for FAK in integrin-mediated survival versus apoptosis?
Meredith and coworkers demonstrated that apoptosis of suspended cells could
be prevented by elevating tyrosine phosphorylation, consistent with, but not
proving, a role for FAK in this process (Meredith et al 1993). The involve-
ment of FAK in apoptosis/survival has been approached recently in several
ways. Reducing the level of FAK in several tumor cell lines with antisense
oligonucleotides induced detachment from the substrate and a high incidence
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of apoptosis (Xu et al 1996). Interestingly, normal cells did not respond by
detachment or apoptosis, which led these investigators to propose targeting
FAK with antisense oligonucleotides as a potential strategy for treating tumors.
However, others have found that perturbations of FAK in normal cells lead to
apoptosis. Apoptosis was induced in chicken embryo fibroblasts by microinjec-
tion of either an antibody against FAK or integrin cytoplasmic domain peptides
that correspond to the region shown to bind FAK in vitro (J Hungerford et al,
manuscript submitted). Epithelial cell lines that go into apoptosis upon suspen-
sion were rescued by transfection with constitutively activated forms of FAK
(Frisch et al 1996). Rescue from apoptosis did not occur if the cells were
transfected with a kinase-dead mutant of FAK or with a mutant in which the
major autophosphorylation site in FAK had been deleted. Together these results
provide strong support for the idea that a major function for FAK is to signal
to a cell that it is in contact with ECM. In the absence of this signal, cells will
go into apoptosis. With tumor cells, growth becomes anchorage independent
owing to activation of oncogenes that short circuit the FAK pathway. It is in-
teresting that many invasive tumors display elevated expression of FAK, which
may contribute to their anchorage-independent growth (Owens et al 1995).
TELEOLOGY
Why do cells in culture form FAs? The existence of FAs and stress fibers is
closely correlated. They have little to do with cell migration; they are absent
from many migratory cells and prominent in the least motile cells (Burridge
1981). In nonmuscle tissues, large bundles of actin filaments, which are con-
tractile, are common in two circumstances: cytokinesis and wound contracture
(Gabbiani et al 1973). We suspect that the origin of stress fibers and FAs reflects
the response of cells in culture to an apparent wound environment. Many of the
agents that activate Rho are released by platelets or other cells in response to
wounding (e.g. LPA, thrombin, endothelin). Some of these factors are present
in serum; thus cells cultured with serum respond as if in a wound. These
factors stimulate Rho-mediated contraction. However, because the underlying
substrate is rigid and the adhesions to it are strong, contraction generates iso-
metric tension, leading to the development of stress fibers and FAs. For most
tissues, wounding is also a potent mitogenic signal. Cells closing a wound pro-
liferate and normally this ceases once the wound has been repaired. A parallel
situation is seen experimentally with cells in collagen gels. If contraction of the
gel is physically restricted, the cells develop isometric tension and prominent
stress fibers (Tomasek et al 1992, Grinnell 1994). Under these conditions, the
cells respond to mitogens by proliferation. Following release of tension, stress
fiber disassembly occurs and is accompanied by a return to quiescence and
a loss of responsiveness to growth factors (Grinnell 1994). Similarly, when
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normal cells in culture are detached from a substrate or are prevented from
spreading and generating tension, they become refractory to growth factors.
Not only does the formation of FAs reflect the response of cells in culture to
a wound environment, but the signaling at FAs may also relate to this wound
response. The clustering of integrins stimulated by contractility activates FAK
and triggers signaling cascades that synergize with growth factors. Together
these responses combine in tissues to close a wound both by contraction and
cell proliferation. In tissue culture, they contribute to the appearance of stress
fibers and FAs and to anchorage-dependent growth.
PERSPECTIVES FOR THE FUTURE
The last few years have witnessed considerable progress in the field of focal
adhesion research. Particularly rapid advances have been made identifying
downstream pathways from Rho. Because of this, it seems likely that the steps
from the activation of Rho to the assembly of focal adhesions will be elucidated
in the near future. Many of the structural interactions that occur in FAs may take
longer to resolve. We anticipate that FAs will continue to serve as a useful model
for studying the signaling that is initiated in response to adhesion to ECM. Many
of the presumptive signaling components in FAs, such as paxillin and p130cas,
have yet to be assigned a function. Experimental strategies aimed at determining
their functions are being actively pursued. Perhaps the greater challenge will be
to unravel the web of signaling pathways that emerge from FAs. The interactions
between integrin-mediated signals and the signals generated in response to
growth factors promise to be fertile grounds, relevant to understanding not only
anchorage-dependent growth, but also differentiation and apoptosis.
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